Call for Abstracts – The Molecular Basis of Life
With this congress, GBM will bring together a wide range of researchers from Germany and from across the globe to explore ‘The Molecular Basis of Life’. The congress will cover the entire spectrum of molecular biosciences with symposia on
• Chromatin and Gene Expression
• Cell Signaling and Membrane Trafficking
• Subcellular Organization
• Molecular Machines
• Molecular Mechanisms of Disease and Therapies
• Emerging Methods
In addition, there will be sessions on research in the bioscience industry, spectroscopic methods and biomarkers, career development and education as well as activities tailored specifically for scientists in the early stages of their careers.
Oral presentations from selected abstracts will provide a forum especially for young scientists within each session and as part of selected short talks and will be chaired by leaders in the field.
Abstract submission:
We kindly request the active participation of young researchers by submitting scientific contributions by June 30, 2017 at http://www.molecular-basis-of-life.org
Important deadlines:
Early registration: May 31, 2017
Abstract submission: June 30, 2017
For further information please visit the conference website http://www.molecular-basis-of-life.org.
http://www.molecular-basis-of-life.org conference website
http://www.gbm-online.de website of the German Society for Biochemistry and Molecular Biology (GBM)
Media Contact
All latest news from the category: Event News
Newest articles
Airborne single-photon lidar system achieves high-resolution 3D imaging
Compact, low-power system opens doors for photon-efficient drone and satellite-based environmental monitoring and mapping. Researchers have developed a compact and lightweight single-photon airborne lidar system that can acquire high-resolution 3D…
Simplified diagnosis of rare eye diseases
Uveitis experts provide an overview of an underestimated imaging technique. Uveitis is a rare inflammatory eye disease. Posterior and panuveitis in particular are associated with a poor prognosis and a…
Targeted use of enfortumab vedotin for the treatment of advanced urothelial carcinoma
New study identifies NECTIN4 amplification as a promising biomarker – Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn…